Pliant Therapeutics, Inc. (NASDAQ:PLRX) Receives Consensus Rating of “Buy” from Analysts
Pliant Therapeutics, Inc. (NASDAQ:PLRX – Get Free Report) has earned a consensus recommendation of “Buy” from the nine research firms that are currently covering the firm, Marketbeat Ratings reports. Eight research analysts have rated the stock with a buy rating and one has given a strong buy rating to the company. The average 1 year […]
More Stories
Armstrong Advisory Group Inc. Purchases 16,585 Shares of Invesco S&P 500 GARP ETF (NYSEARCA:SPGP)
Armstrong Advisory Group Inc. boosted its stake in Invesco S&P 500 GARP ETF (NYSEARCA:SPGP – Free Report) by 7.3% during...
Lamb Weston Holdings, Inc. (NYSE:LW) Stock Holdings Increased by Inspire Investing LLC
Inspire Investing LLC boosted its stake in shares of Lamb Weston Holdings, Inc. (NYSE:LW – Free Report) by 5.6% during...
Inspire Investing LLC Buys 32,768 Shares of Medifast, Inc. (NYSE:MED)
Inspire Investing LLC increased its stake in Medifast, Inc. (NYSE:MED – Free Report) by 203.5% in the third quarter, according...
Annex Advisory Services LLC Grows Holdings in Hawkins, Inc. (NASDAQ:HWKN)
Annex Advisory Services LLC lifted its position in shares of Hawkins, Inc. (NASDAQ:HWKN – Free Report) by 6.0% during the...
PlatinX Trading 0% Lower This Week (PTX)
PlatinX (PTX) traded down 0% against the dollar during the 1 day period ending at 7:00 AM ET on October...
KickToken Price Down 5.2% Over Last 7 Days (KICK)
KickToken (KICK) traded up 0.5% against the dollar during the 24-hour period ending at 7:00 AM Eastern on October 14th....